Cat. No.: X23-10-ZQ181
RIP kinase inhibitor GSK583, Purity ≥98%
Synonym: 1346547-00-9; GSK583; GSK 583; 6-(tert-Butylsulfonyl)-N-(5-fluoro-2H-indazol-3-Yl)quinolin-4-Amine; 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine; 6-tert-Butylsulfonyl-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine; RIP kinase inhibitor
- MDL: MFCD30343846
- CAS Number: 1346547-00-9
- Compound CID: 67469084
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
GSK583, soluble in DMSO and ethanol and insoluble in water, is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Formula
C20H19FN4O2S
Solubility
DMSO: 72 mg/mL (180.69 mM); Water: Insoluble; Ethanol: 25 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK583 can be used to investigate the inhibition of RIPK2 and its potential therapeutic applications.
Related Products
Quick Links